Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Dipivefrine

From Wikipedia, the free encyclopedia
Chemical compound

"Propine" redirects here. For the hydrocarbon compound, seepropyne.
Pharmaceutical compound
Dipivefrine
Clinical data
Trade namesAKPro, D Epifrin, Diopine, Glaucothil, Pro-Epinephrine, Propine, Pivalephrine, Thilodrin, Vistapine, others
Other namesDipivefrin; Dipivephrine; Dipivephrin; Dipivalyl epinephrine; Dipivalylepinephrine; DPE; Epinephrine dipivalate; Epinephrine dipivalate ester; Adrenaline dipivalate; Dipivalyl adrenaline; Dipivalyladrenaline; K-30081; 3,4-Dipivalyloxy-β-hydroxy-N-methylphenethylamine; 3,4-Dipivalyloxy-β-hydroxy-N-methyl-β-phenylethylamine
AHFS/Drugs.comInternational Drug Names
MedlinePlusa686005
Routes of
administration
Eye drops[1]
Drug classAdrenergic receptor agonist;Sympathomimetic
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • [2-(2,2-Dimethylpropanoyloxy)-4-(1-hydroxy-2-methylamino-ethyl)-phenyl] 2,2-dimethylpropanoate
CAS Number
PubChemCID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC19H29NO5
Molar mass351.443 g·mol−1
3D model (JSmol)
  • O=C(Oc1cc(ccc1OC(=O)C(C)(C)C)C(O)CNC)C(C)(C)C
  • InChI=1S/C19H29NO5/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6/h8-10,13,20-21H,11H2,1-7H3 checkY
  • Key:OCUJLLGVOUDECM-UHFFFAOYSA-N checkY
  (verify)

Dipivefrine, ordipivefrin, also known asepinephrine pivalate and sold under the brand namePropine among others, is asympathomimeticmedication which is used in the treatment ofopen-angle glaucoma.[2][3] It is available as a 0.1%ophthalmicsolution (eye drop).[1][4]

Side effects of dipivefrine include local eye reactions among others. Dipivefrine is aprodrug ofepinephrine (adrenaline) and hence acts as anon-selectiveadrenergic receptoragonist.[5] It is asubstituted phenethylamine andcatecholamine and is anester of epinephrine with much greaterfat solubility.[6][7][8]

Dipivefrine was first described by 1975.[9] It is widely marketed throughout the world.[10] However, it is no longer available in theUnited States.[11]

Medical uses

[edit]

Dipivefrine is used in the treatment ofopen-angle glaucoma.[2]

Contraindications

[edit]

Use innarrow-angle glaucoma may be dangerous because it could make the eye susceptible to an attack of angle closure,[3] causing an increase in pressure and pain and possibly loss of vision.

Side effects

[edit]

The most commonside effects of dipivefrine are burning, stinging, and other irritations of the eye. Possible but uncommon side effects are the same as those of epinephrine and includetachycardia (fast heartbeat),hypertension (high blood pressure) andarrhythmias (irregular heartbeat).[3]

Pharmacology

[edit]

Dipivefrine penetrates thecornea and is thenhydrolysed to epinephrine byesteraseenzymes.[8] It increases outflow of theaqueous humour and also reduces its formation (mediated by its action onα1- andα2-adrenergic receptors), thus reducingpressure inside the eye. It also increases the conductivity oftrabecular filtering cells (aβ2-adrenergic-receptor-mediated action). It is preferred to epinephrine because it is longer-acting, more consistent in its action, and better-tolerated.[2]

Chemistry

[edit]

Dipivefrine, also known as epinephrine dipivalate or as 3,4-dipivalyloxy-β-hydroxy-N-methylphenethylamine, is asubstituted phenethylamine andcatecholamine.[6] It is the 3,4-dipivalateester ofepinephrine (adrenaline).[6]

The experimentallog P of dipivefrine is 1.7 and its predicted log P ranges from 1.49 to 3.71.[6][1][12] It is dramatically morelipophilic (600-fold) than epinephrine,[7][8][4] which is highlyhydrophilic and has a log P of -1.37.[13] The lipophilicity of dipivefrine allows it to penetrate thecornea much more readily (17-fold) than epinephrine.[7][8][4] Eye drops containing 0.1% dipivefrine have similar effectiveness to conventional eye drops containing 2% epinephrine in loweringintraocular pressure.[4]

Dipivefrine is usedpharmaceutically mainly as thehydrochloridesalt.[14][10]

A similarcompound that was never marketed ispivenfrine, which is the 3-pivalate ester ofphenylephrine.[14]

History

[edit]

Dipivefrine was first described in thescientific literature by 1975.[9]

Society and culture

[edit]

Names

[edit]

Dipivefrine is thegeneric name of the drug and itsINNTooltip International Nonproprietary Name,BANTooltip British Approved Name, andDCFTooltip Dénomination Commune Française, whiledipivefrin is itsUSANTooltip United States Adopted Name anddipivefrina is itsDCITTooltip Denominazione Comune Italiana.[14][10][15] In the case of thehydrochloridesalt,dipivefrine hydrochloride is itsBANMTooltip British Approved Name whiledipivefrin hydrochloride is itsUSANTooltip United States Adopted Name andJANTooltip Japanese Accepted Name.[14][10][15]

Synonyms of dipivefrine includeepinephrine pivalate,adrenaline pivalate, anddipivalyl epinephrine, among others.[14][10]

Dipivefrine has been sold under brand names includingDiopine,Glaucothil,Pro-Epinephrine,Propine,Thilodrin, andVistapine, among many others.[14][10]

See also

[edit]

References

[edit]
  1. ^abc"Dipivefrin: Uses, Interactions, Mechanism of Action".DrugBank Online. 31 December 1995. Retrieved31 August 2024.
  2. ^abcKD Tripari (2004).Essentials of Medical Pharmacology (5 ed.). Jaypee Brothers Medical Publishers(P) Ltd. p. 88.ISBN 81-8061-187-6.
  3. ^abcDipivefrinFDA Professional Drug Information.
  4. ^abcdBaranowski P, Karolewicz B, Gajda M, Pluta J (2014)."Ophthalmic drug dosage forms: characterisation and research methods".ScientificWorldJournal.2014 861904.doi:10.1155/2014/861904.PMC 3977496.PMID 24772038.
  5. ^Arthur S, Cantor LB (September 2011). "Update on the role of alpha-agonists in glaucoma management".Exp Eye Res.93 (3):271–283.doi:10.1016/j.exer.2011.04.002.PMID 21524649.
  6. ^abcd"Dipivefrin".PubChem. Retrieved31 August 2024.
  7. ^abcGoldberg I, Kolker AE, Kass MA, Becker B (May 1980). "Dipivefrin: current concepts".Aust J Ophthalmol.8 (2):147–150.doi:10.1111/j.1442-9071.1980.tb01673.x.PMID 7004425.
  8. ^abcdStella V, Borchardt R, Hageman M, Oliyai R, Maag H, Tilley J (2007).Prodrugs: Challenges and Rewards. Biotechnology: Pharmaceutical Aspects. Springer New York. p. 130.ISBN 978-0-387-49782-2. Retrieved2024-08-31.
  9. ^abMcClure DA (1 June 1975). "The Effect of a Pro-drug of Epinephrine (Dipivalyl Epinephrine) in Glaucoma—General Pharmacology, Toxicology, and Clinical Experience".Pro-drugs as Novel Drug Delivery Systems. ACS Symposium Series. Vol. 14. Washington, D. C.: American Chemical Society. pp. 225–235.doi:10.1021/bk-1975-0014.ch006.ISBN 978-0-8412-0291-7.
  10. ^abcdefSchweizerischer Apotheker-Verein (2004).Index Nominum: International Drug Directory. Medpharm Scientific Publishers. p. 411.ISBN 978-3-88763-101-7. Retrieved2024-08-31.
  11. ^Zhang L, Weizer JS, Musch DC (2017)."Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty".Cochrane Database Syst Rev.2017 (2) CD010746.doi:10.1002/14651858.CD010746.pub2.PMC 5477062.PMID 28231380.
  12. ^"C19H29NO5".Dipivefrin (in Latin). 31 August 2024. Retrieved31 August 2024.
  13. ^"Epinephrine".PubChem. Retrieved31 August 2024.
  14. ^abcdefElks J (2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. pp. 455, 1001.ISBN 978-1-4757-2085-3. Retrieved2024-08-31.
  15. ^abMorton IK, Hall JM (2012).Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Netherlands. p. 101.ISBN 978-94-011-4439-1. Retrieved31 August 2024.
Drugs used forglaucoma preparations andmiosis (S01E)
Sympathomimetics
Parasympathomimetics
muscarinic
muscarinic/nicotinic
acetylcholinesterase inhibitors
Carbonic anhydrase inhibitors/
(sulfonamides)
Beta blocking agents
Prostaglandin analogues (F)
Other agents
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
Retrieved from "https://en.wikipedia.org/w/index.php?title=Dipivefrine&oldid=1313988093"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp